| Judith Lovell, | |
|
1120 S Gurn Cir, Palmer, AK 99645-6522 | |
| (907) 707-3888 | |
| Not Available |
| Full Name | Judith Lovell |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1120 S Gurn Cir, Palmer, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922465848 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 100142 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judith Lovell, 1120 S Gurn Cir, Palmer, AK 99645-6522 Ph: () - | Judith Lovell, 1120 S Gurn Cir, Palmer, AK 99645-6522 Ph: (907) 707-3888 |
News Archive
Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.
Scientists from the Helmholtz Zentrum Muenchen and the Technische Universitaet Muenchen, together with scientists in the USA, have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.
GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.
A drug widely used to treat type 2 diabetes has been found to reduce the risk of death, heart attack (myocardial infarction) or stroke when used alone or in combination with other therapies for diabetes, according to a Cleveland Clinic study.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
› Verified 9 days ago
Elizabeth Truett, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4404 S Silver Bullet Cir, Palmer, AK 99645 Phone: 907-745-5776 | |
Courtney Randol, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14405 E Pace Dr., Palmer, AK 99645 Phone: 907-746-1563 | |
Melody Kirchner, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5451 N Maverick Dr, Palmer, AK 99645 Phone: 907-746-1491 |